United States Platelet Rich Plasma Market Report by Product Type (Pure Platelet-Rich Plasma (P-PRP), Leukocyte- and Platelet-Rich Plasma (LPRP), Leukocyte- and Platelet-Rich Fibrin (L-PRF), Pure Platelet-Rich Fibrin (P-PRF)), Origin (Autologous PRP, Homologous PRP, Allogeneic PRP), Application (Orthopedics, Cosmetic Surgery and Dermatology, Neurosurgery, General Surgery, Cardiothoracic Surgery, Urology, Ophthalmology, and Others), End User (Hospitals and Clinics, Research Institutes, and Others), and Region 2025-2033

United States Platelet Rich Plasma Market Report by Product Type (Pure Platelet-Rich Plasma (P-PRP), Leukocyte- and Platelet-Rich Plasma (LPRP), Leukocyte- and Platelet-Rich Fibrin (L-PRF), Pure Platelet-Rich Fibrin (P-PRF)), Origin (Autologous PRP, Homologous PRP, Allogeneic PRP), Application (Orthopedics, Cosmetic Surgery and Dermatology, Neurosurgery, General Surgery, Cardiothoracic Surgery, Urology, Ophthalmology, and Others), End User (Hospitals and Clinics, Research Institutes, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A3291

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   United States Platelet Rich Plasma Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product Type
    6.1    Pure Platelet-Rich Plasma (P-PRP)
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Leukocyte- and Platelet-Rich Plasma (LPRP)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Leukocyte- and Platelet-Rich Fibrin (L-PRF) 
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Pure Platelet-Rich Fibrin (P-PRF)
        6.4.1 Market Trends
        6.4.2 Market Forecast
7   Market Breakup by Origin
    7.1    Autologous PRP
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Homologous PRP
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Allogeneic PRP
        7.3.1 Market Trends
        7.3.2 Market Forecast
8   Market Breakup by Application
    8.1    Orthopedics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Cosmetic Surgery and Dermatology
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Neurosurgery
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    General Surgery
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Cardiothoracic Surgery
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Urology
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Ophthalmology
        8.7.1 Market Trends
        8.7.2 Market Forecast
    8.8    Others
        8.8.1 Market Trends
        8.8.2 Market Forecast
9   Market Breakup by End User
    9.1    Hospitals and Clinics
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Research Institutes 
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1 Northeast
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2 Midwest
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3 South
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4 West
        10.4.1 Market Trends
        10.4.2 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Arteriocyte Medical Systems Inc. (Isto Technologies II LLC)
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 SWOT Analysis
        15.3.2    Arthrex Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio 
        15.3.3    Depuy Synthes Inc. (Johnson & Johnson)
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
           15.3.3.3 Financials
        15.3.4    Dr Prp USA LLC
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
        15.3.5    EmCyte Corporation
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
        15.3.6    Exactech Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio 
        15.3.7    Glofinn America LLC (Glofinn Co. Ltd.)
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio 
        15.3.8    Regen Lab USA LLC
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio 
        15.3.9    Stryker Corporation
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio 
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    Terumo BCT Inc. (Terumo Corporation)
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio 
           15.3.10.3 Financials
           15.3.10.4 SWOT Analysis
        15.3.11    ThermoGenesis Holdings Inc.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio 
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Zimmer Biomet Holdings Inc.
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio 
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis

List of Figures

Figure 1: United States: Platelet Rich Plasma Market: Major Drivers and Challenges
Figure 2: United States: Platelet Rich Plasma Market: Sales Value (in Million USD), 2019-2024
Figure 3: United States: Platelet Rich Plasma Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 4: United States: Platelet Rich Plasma Market: Breakup by Product Type (in %), 2024
Figure 5: United States: Platelet Rich Plasma Market: Breakup by Origin (in %), 2024
Figure 6: United States: Platelet Rich Plasma Market: Breakup by Application (in %), 2024
Figure 7: United States: Platelet Rich Plasma Market: Breakup by End User (in %), 2024
Figure 8: United States: Platelet Rich Plasma Market: Breakup by Region (in %), 2024
Figure 9: United States: Platelet Rich Plasma (Pure Platelet-Rich Plasma (P-PRP)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: United States: Platelet Rich Plasma (Pure Platelet-Rich Plasma (P-PRP)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Plasma (LPRP)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Plasma (LPRP)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Fibrin (L-PRF) ) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: United States: Platelet Rich Plasma (Leukocyte- and Platelet-Rich Fibrin (L-PRF) ) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: United States: Platelet Rich Plasma (Pure Platelet-Rich Fibrin (P-PRF)) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: United States: Platelet Rich Plasma (Pure Platelet-Rich Fibrin (P-PRF)) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: United States: Platelet Rich Plasma (Autologous PRP) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: United States: Platelet Rich Plasma (Autologous PRP) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: United States: Platelet Rich Plasma (Homologous PRP) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: United States: Platelet Rich Plasma (Homologous PRP) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: United States: Platelet Rich Plasma (Allogeneic PRP) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: United States: Platelet Rich Plasma (Allogeneic PRP) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: United States: Platelet Rich Plasma (Orthopedics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: United States: Platelet Rich Plasma (Orthopedics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: United States: Platelet Rich Plasma (Cosmetic Surgery and Dermatology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: United States: Platelet Rich Plasma (Cosmetic Surgery and Dermatology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: United States: Platelet Rich Plasma (Neurosurgery) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: United States: Platelet Rich Plasma (Neurosurgery) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: United States: Platelet Rich Plasma (General Surgery) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: United States: Platelet Rich Plasma (General Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: United States: Platelet Rich Plasma (Cardiothoracic Surgery) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: United States: Platelet Rich Plasma (Cardiothoracic Surgery) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: United States: Platelet Rich Plasma (Urology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: United States: Platelet Rich Plasma (Urology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: United States: Platelet Rich Plasma (Ophthalmology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: United States: Platelet Rich Plasma (Ophthalmology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: United States: Platelet Rich Plasma (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: United States: Platelet Rich Plasma (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: United States: Platelet Rich Plasma (Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: United States: Platelet Rich Plasma (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: United States: Platelet Rich Plasma (Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: United States: Platelet Rich Plasma (Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: United States: Platelet Rich Plasma (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: United States: Platelet Rich Plasma (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Northeast: Platelet Rich Plasma Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Northeast: Platelet Rich Plasma Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Midwest: Platelet Rich Plasma Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Midwest: Platelet Rich Plasma Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: South: Platelet Rich Plasma Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: South: Platelet Rich Plasma Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: West: Platelet Rich Plasma Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: West: Platelet Rich Plasma Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: United States: Platelet Rich Plasma Industry: SWOT Analysis
Figure 54: United States: Platelet Rich Plasma Industry: Value Chain Analysis
Figure 55: United States: Platelet Rich Plasma Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: United States: Platelet Rich Plasma Market: Key Industry Highlights, 2024 and 2033
Table 2: United States: Platelet Rich Plasma Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
Table 3: United States: Platelet Rich Plasma Market Forecast: Breakup by Origin (in Million USD), 2025-2033
Table 4: United States: Platelet Rich Plasma Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 5: United States: Platelet Rich Plasma Market Forecast: Breakup by End User (in Million USD), 2025-2033
Table 6: United States: Platelet Rich Plasma Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: United States: Platelet Rich Plasma Market: Competitive Structure
Table 8: United States: Platelet Rich Plasma Market: Key Players

United States Platelet Rich Plasma Market Report by Product Type (Pure Platelet-Rich Plasma (P-PRP), Leukocyte- and Platelet-Rich Plasma (LPRP), Leukocyte- and Platelet-Rich Fibrin (L-PRF), Pure Platelet-Rich Fibrin (P-PRF)), Origin (Autologous PRP, Homologous PRP, Allogeneic PRP), Application (Orthopedics, Cosmetic Surgery and Dermatology, Neurosurgery, General Surgery, Cardiothoracic Surgery, Urology, Ophthalmology, and Others), End User (Hospitals and Clinics, Research Institutes, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials